← Leaderboards
David Scott Wilson
Johns Hopkins University
$3,561,564
Attributed
$3,561,564
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $941.6K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,561,564 · 3
By mechanism
DP2$2,456,250 · 1
R21$1,105,314 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert A Wood$78,863,893
- Bruce S Bochner$17,391,451
- Noel R. Rose$9,060,278
- Corinne Keet$22,056,351
- Charles W. Flexner$41,000,447
Others in their field
Other Emerging Leaders on “Binding”
- Xinhua Li · Nano Terra, Inc.$35,520,438
- John Damon Chodera · Sloan-Kettering Inst Can Research$21,305,909
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Kristian Graugaard Andersen · Scripps Research Institute, The$18,732,618
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
BindingPolymersImmune ResponseDesignBiocompatible MaterialsPeptidesT-LymphocyteMediatingMonomerWaterNoseMucous Body SubstanceMouse ModelNasal EpitheliumImmunizeLymphoid TissuePre-ClinicalEfficacy ValidationDi-Block CopolymerImmuneFlow CytometryLabelAntigensTight Junctions
Grant awards (10)
Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity$491,250
DP2 · FY2025 · AI · contact PI
Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity$491,250
DP2 · FY2024 · AI · contact PI
Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity$491,250
DP2 · FY2023 · AI · contact PI
A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2$245,625
R21 · FY2023 · EB · contact PI
Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity$491,250
DP2 · FY2022 · AI · contact PI
The first polymeric opioid conjugate vaccine$245,625
R21 · FY2022 · DA · contact PI
A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2$204,688
R21 · FY2022 · EB · contact PI
Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity$491,250
DP2 · FY2021 · AI · contact PI
A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2$204,688
R21 · FY2021 · EB · contact PI
The first polymeric opioid conjugate vaccine$204,688
R21 · FY2021 · DA · contact PI